Fintel reports that on July 3, 2023, Morgan Stanley maintained coverage of Sigilon Therapeutics (NASDAQ:SGTX) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 128.93% Upside As of June 2, 2023, the average one-year price target for Sigilon Therapeutics is 51.51. The forecasts range from a low of 7.07 to a high of $95.55. The average...
Author: Fintel
Chardan Capital Reiterates Femasys (FEMY) Buy Recommendation
Fintel reports that on July 3, 2023, Chardan Capital reiterated coverage of Femasys (NASDAQ:FEMY) with a Buy recommendation. Analyst Price Forecast Suggests 1,450.00% Upside As of June 2, 2023, the average one-year price target for Femasys is 7.90. The forecasts range from a low of 5.05 to a high of $11.55. The average price target...
JP Morgan Maintains Ternium S.A. – ADR (TX) Overweight Recommendation
Fintel reports that on June 30, 2023, JP Morgan maintained coverage of Ternium S.A. – ADR (NYSE:TX) with a Overweight recommendation. Analyst Price Forecast Suggests 28.91% Upside As of June 2, 2023, the average one-year price target for Ternium S.A. – ADR is 51.14. The forecasts range from a low of 42.42 to a high...
Raymond James Maintains Weave Communications (WEAV) Outperform Recommendation
Fintel reports that on June 30, 2023, Raymond James maintained coverage of Weave Communications (NYSE:WEAV) with a Outperform recommendation. Analyst Price Forecast Suggests 42.82% Downside As of June 2, 2023, the average one-year price target for Weave Communications is 6.19. The forecasts range from a low of 5.05 to a high of $7.88. The average...
HC Wainwright & Co. Reiterates Aldeyra Therapeutics (ALDX) Buy Recommendation
Fintel reports that on June 30, 2023, HC Wainwright & Co. reiterated coverage of Aldeyra Therapeutics (NASDAQ:ALDX) with a Buy recommendation. Analyst Price Forecast Suggests 164.68% Upside As of June 2, 2023, the average one-year price target for Aldeyra Therapeutics is 20.91. The forecasts range from a low of 13.13 to a high of $31.50....
B of A Securities Initiates Coverage of U.S. Physical Therapy (USPH) with Buy Recommendation
Fintel reports that on June 30, 2023, B of A Securities initiated coverage of U.S. Physical Therapy (NYSE:USPH) with a Buy recommendation. Analyst Price Forecast Suggests 3.29% Upside As of June 2, 2023, the average one-year price target for U.S. Physical Therapy is 121.04. The forecasts range from a low of 116.15 to a high...
RBC Capital Reiterates Catalent (CTLT) Outperform Recommendation
Fintel reports that on June 30, 2023, RBC Capital reiterated coverage of Catalent (NYSE:CTLT) with a Outperform recommendation. Analyst Price Forecast Suggests 19.50% Upside As of June 2, 2023, the average one-year price target for Catalent is 48.20. The forecasts range from a low of 28.28 to a high of $90.30. The average price target...
JP Morgan Maintains Zions Bancorporation N.A (ZION) Overweight Recommendation
Fintel reports that on June 29, 2023, JP Morgan maintained coverage of Zions Bancorporation N.A (NASDAQ:ZION) with a Overweight recommendation. Analyst Price Forecast Suggests 39.98% Upside As of June 1, 2023, the average one-year price target for Zions Bancorporation N.A is 37.92. The forecasts range from a low of 28.28 to a high of $52.50....
Wells Fargo Upgrades Pinterest Inc – (PINS)
Fintel reports that on June 28, 2023, Wells Fargo upgraded their outlook for Pinterest Inc – (NYSE:PINS) from Equal-Weight to Overweight . Analyst Price Forecast Suggests 10.46% Upside As of June 2, 2023, the average one-year price target for Pinterest Inc – is 29.16. The forecasts range from a low of 19.19 to a high...
Stifel Upgrades Guidewire Software (GWRE)
Fintel reports that on June 27, 2023, Stifel upgraded their outlook for Guidewire Software (NYSE:GWRE) from Hold to Buy . Analyst Price Forecast Suggests 21.04% Upside As of June 1, 2023, the average one-year price target for Guidewire Software is 84.15. The forecasts range from a low of 60.60 to a high of $99.75. The...